First-in-Human Trial of a STAT3 Decoy Oligonucleotide in Head and Neck Tumors: Implications for Cancer Therapy
Malabika Sen(University of Pittsburgh Medical Center), Jennifer R. Grandis(University of California, San Francisco), Kusum Pandit(University of Pittsburgh), William E. Gooding(UPMC Hillman Cancer Center), Sonali Joyce(University of Pittsburgh), Pui‐Kai Li(University of Pittsburgh), Umamaheswar Duvvuri(City University of New York), Nivedita Sahu(University of Pittsburgh), Daniel E. Johnson(UCSF Helen Diller Family Comprehensive Cancer Center), Raja R. Seethala(University of Pittsburgh), Danith H. Ly(Carnegie Mellon University), Sufi M. Thomas(University of New Mexico), Jonathan P. Etter(University of Pittsburgh), Simion I. Chiosea(University of Pittsburgh), Robert L. Ferris(University of Pittsburgh), Srinivas Rapireddy(University of Pittsburgh), Naftali Kaminski(Yale University), Lin Wang(Zhuzhou Central Hospital), Seungwon Kim(UPMC Hillman Cancer Center), Jessica Lee(Foundation Medicine (United States)), Changyou Li(Qingdao Agricultural University), Joanne I. Yeh(University of Pittsburgh), Jonas T. Johnson(University of Pittsburgh), Maria L. Freilino(The University of Texas MD Anderson Cancer Center), Haibin Shi(University of Pittsburgh)
Cited by 313
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Head and neck squamous cell carcinoma
|Nature Reviews Disease Primers|2020|4k
Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis
|Science Advances|2020|1.5k
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma
|JAMA Oncology|2016|1.4k